Invictus MD Strategies (IVITF) Stock Price, News & Analysis

Company Overview

Invictus MD Strategies Corp. is a Canada-based health and wellness company with a focus on the development, manufacturing and distribution of botanical-based products. Founded in 2017 and headquartered in Toronto, Ontario, the company is publicly traded on the OTC Markets under the ticker IVITF. Invictus MD Strategies has built a diversified portfolio of subsidiaries and brands that span the life cycle of botanical wellness products, from research and development through to production and retail.

The company’s core business activities center on the formulation and manufacturing of cannabis- and hemp-derived products for medical and adult-use markets. Invictus operates a network of manufacturing facilities, including a Good Manufacturing Practices (GMP)–certified laboratory, where it produces a range of ingestible, topical and inhalation delivery systems. Its product suite includes soft gels, oils, balms, transdermal patches and precision inhalers, all formulated to meet pharmaceutical standards for quality and consistency.

In addition to its manufacturing arm, Invictus MD Strategies has invested in branded consumer products and retail channels. The company’s consumer-facing brands address segments such as sports recovery, mental wellness and elder care, offering targeted formulations that combine cannabinoids with complementary nutraceutical ingredients. Invictus also partners with third-party distributors and pharmacy networks to expand its reach, supporting both online and brick-and-mortar sales across multiple jurisdictions.

Invictus MD Strategies maintains a presence in key North American markets, with operations spanning Canada and selected U.S. states where its product lines comply with local regulations. Leadership is led by Chief Executive Officer Nicholas Vita, whose background in pharmaceuticals and biotechnology has guided the company’s strategic focus on innovation and regulatory compliance. Under Vita’s stewardship, Invictus has pursued strategic acquisitions to enhance its product pipeline and manufacturing capabilities, positioning the company to serve the evolving global demand for plant-based health solutions.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 4,000 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IVITF Stock Analysis - Frequently Asked Questions

How do I buy shares of Invictus MD Strategies?

Shares of IVITF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:IVITF
• CIK: 1737647
• Web: invictus-md.com
• Phone: (647) 828-9655
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A